Introduction
Alzheimer's disease (AD) is characterized by the accumulation of fibrillar deposits in the brain. The major constituent of the extracellular amyloid plaques is the β-amyloid protein or Aβ, a polypeptide generated by the processing of β-amyloid precursor protein (APP) (Masters et al., 1985) . Also, abnormally phosphorylated forms of the tau protein are the basic component of intracellular neurofibrillary tangles (Grundke-Iqbal et al., 1986) . Reelin is an extracellular glycoprotein that is required for the development and maturation of the brain (Rice and Curran, 2001; Tissir and Goffinet, 2003) and modulates synaptic function and plasticity in the mature brain, thereby favouring memory formation (Weeber et al., 2002; Beffert et al., 2005; 2006; Herz and Chen, 2006; Groc et al., 2007; Levenson et al., 2008) .
Interestingly, and although the role of Reelin in the adult and senescent brain is largely unknown, increasing evidence supports a link between Reelin and components of its signaling pathway with the main hallmarks of AD pathology (reviewed in Botella-López and Sáez-Valero, 2008) . First, Reelin competes with apolipoprotein E (ApoE) for binding to the ApoE receptors, ApoER2 and VLDLR (D'Arcangelo et al., 1999; Hiesberger et al., 1999) , and ApoE ɛ4, the major known genetic risk factor for AD, is one of the strongest competitors (D'Arcangelo et al., 1999) . A direct role for ApoER2 on amyloid deposition and neurodegeneration in AD has also been suggested (Motoi et al., 2004) . In addition, Reelin receptors convey intracellular signals through the adaptor Dab1 (Bar and Goffinet, 1999; Cooper and Howell, 1999; Trommsdorff et al., 1999) , thereby leading to a signaling cascade that ultimately controls glycogen synthase kinase-3β (GSK-3β) (Beffert et al., 2002) , an enzyme that regulates phosphorylation of the microtubule binding protein tau. Another kinase that phosphorylates tau, the cyclin-dependent kinase 5 (CDK5), is also considered a potential downstream effector for the Reelin signaling pathway (Rice and Curran, 2001 ). Finally, AD-causative gene products result in earlier, higher, and more persistent levels of Reelin-positive deposits (Knuesel et al. 2009 ) and it has been shown that Reelin treatment increases APP cleavage and decreases Aβ production (Hoe et al., 2006) . More recently, it has been shown that Reelin can interact with the extracellular domain of APP (Hoe et al., 2009 ). Dab1 also binds to APP (Trommsdorff et al., 1998; Howell et al., 1999) and influences APP trafficking and processing (Parisiadou and Efthimiopoulos, 2007; Hoe et al., 2006) . Therefore, Reelin and components of its signaling 
